Your browser doesn't support javascript.
loading
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately, L; Mesía, C; Sepúlveda, J M; Del Barco, S; Pineda, E; Gironés, R; Fuster, J; Hong, W; Dumas, M; Gill, S; Navarro, L M; Herrero, A; Dowling, A; de Las Peñas, R; Vaz, M A; Alonso, M; Lwin, Z; Harrup, R; Peralta, S; Long, A; Perez-Segura, P; Ahern, E; Garate, C O; Wong, M; Campbell, R; Cuff, K; Jennens, R; Gallego, O; Underhill, C; Martinez-Garcia, M; Covela, M; Cooper, A; Brown, S; Rosenthal, M; Torres, J; Collins, I M; Gibbs, P; Balana, C.
Afiliación
  • Gately L; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. gately.l@wehi.edu.au.
  • Mesía C; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia. gately.l@wehi.edu.au.
  • Sepúlveda JM; Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain.
  • Del Barco S; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Pineda E; Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain.
  • Gironés R; Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Fuster J; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain.
  • Hong W; Medical Oncology Service, Hospital Son Espases, Palma de Mallorca, Spain.
  • Dumas M; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Gill S; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Navarro LM; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia.
  • Herrero A; Medical Oncology Service, Hospital de Salamanca, Salamanca, Spain.
  • Dowling A; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain.
  • de Las Peñas R; Department of Medical Oncology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
  • Vaz MA; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain.
  • Alonso M; Medical Oncology Service, Hospital Ramón y Cajal, Madrid, Spain.
  • Lwin Z; Medical Oncology Service, Hospital Virgen del Rocio, Seville, Spain.
  • Harrup R; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Peralta S; Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia.
  • Long A; Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain.
  • Perez-Segura P; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Ahern E; Medical Oncology Service, Hospital Clinico San Carlos, Madrid, Spain.
  • Garate CO; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia.
  • Wong M; Medical Oncology Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
  • Campbell R; Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia.
  • Cuff K; Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia.
  • Jennens R; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Gallego O; Department of Medical Oncology, Epworth Health, Richmond, VIC, Australia.
  • Underhill C; Medical Oncology Service, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Martinez-Garcia M; Department of Medical Oncology, Border Medical Oncology, East Albury, NSW, Australia.
  • Covela M; Medical Oncology Service, Hospital del Mar, Barcelona, Spain.
  • Cooper A; Medical Oncology Service, Hospital Lucus Augusti, Lugo, Spain.
  • Brown S; Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia.
  • Rosenthal M; Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia.
  • Torres J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Collins IM; Department of Medical Oncology, Goulburn Valley Health, Shepparton, VIC, Australia.
  • Gibbs P; Department of Medical Oncology, South West Regional Cancer Centre, Geelong, VIC, Australia.
  • Balana C; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
J Neurooncol ; 166(3): 417-418, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38289531
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: J Neurooncol Año: 2024 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: J Neurooncol Año: 2024 Tipo del documento: Article País de afiliación: Australia